CBAY - Cymabay Therapeu - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CBAY is currently covered by 11 analysts with an average price target of $35.9. This is a potential upside of $3.42 (10.53%) from yesterday's end of day stock price of $32.48.

Cymabay Therapeu's activity chart (see below) currently has 92 price targets and 113 ratings on display. The stock rating distribution of CBAY is 77.78% BUY and 22.22% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 79.98% with an average time for these price targets to be met of 498.69 days.

Highest price target for CBAY is $32.5, Lowest price target is $32.5, average price target is $35.9.

Most recent stock forecast was given by ED ARCE from HC WAINWRIGHT on 29-Feb-2024.

Currently out of the existing stock ratings of CBAY, 35 are a BUY (77.78%), 10 are a HOLD (22.22%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$32.5

$0.02 (0.06%)

8 months 19 days ago
(29-Feb-2024)

17/18 (94.44%)

$0.31 (0.96%)

627

Hold

$32.5

$0.02 (0.06%)

$12

8 months 28 days ago
(20-Feb-2024)

2/3 (66.67%)

$0.3 (0.93%)

129

Hold

$32.5

$0.02 (0.06%)

$33

9 months 3 days ago
(14-Feb-2024)

11/13 (84.62%)

$0.32 (0.99%)

875

Hold

$32.5

$0.02 (0.06%)

$25

9 months 3 days ago
(14-Feb-2024)

8/9 (88.89%)

$0.32 (0.99%)

891

Hold

$32.5

$0.02 (0.06%)

$34

9 months 4 days ago
(13-Feb-2024)

9/12 (75%)

$0.38 (1.18%)

1210

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CBAY (Cymabay Therapeu) average time for price targets to be met?

On average it took 498.69 days on average for the stock forecasts to be realized with a an average price target met ratio 79.98

Which analyst has the current highest performing score on CBAY (Cymabay Therapeu) with a proven track record?

ELIANA MERLE

Which analyst has the most public recommendations on CBAY (Cymabay Therapeu)?

Eliana Merle works at UBS and has 6 price targets and 4 ratings on CBAY

Which analyst is the currently most bullish on CBAY (Cymabay Therapeu)?

Kristen Kluska with highest potential upside - $0.02

Which analyst is the currently most reserved on CBAY (Cymabay Therapeu)?

Joel Beatty with lowest potential downside - -$22.48

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?